Lukas Löfling

11PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 27, 2025
Beta-blockers and epithelial ovarian cancer survival: A Norwegian population-based cohort study.

Leif Lukas Löfling, Nathalie C Støer, Erica K Sloan

|Feb 01, 2024
Low-Dose Aspirin and Prevention of Colorectal Cancer: Evidence From a Nationwide Registry-Based Cohort in Norway.

Sara Nafisi, Nathalie C Støer, Marit B Veierød

|Aug 30, 2023
Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.

L Lukas Löfling, Nathalie C Støer, Bettina Kulle Andreassen

|Apr 26, 2023
Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer.

Aeson Chang, Edoardo Botteri, Ryan D Gillis

|Mar 06, 2023
Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women.

Lukas Løfling, Nathalie C Støer, Sara Nafisi

|Dec 10, 2022
Validation of safety outcomes in routinely collected data: Lessons learned from a multinational postapproval safety study.

Patrick J Arena, Kui Huang, Lukas Löfling

Pageof 2

Frequent Collaborators

6 joint publications

Edoardo Botteri

3 joint publications

Nathalie C Støer

3 joint publications

Sara Nafisi

2 joint publications

Erica K Sloan